Standardized PRP Hair Loss Protocol: What It Must Specify
What defines a standardized PRP protocol for hair loss and why does standardization matter?
PRP isn't a drug with a printed dose on the box. It's a biologic made from your own blood in the room next door, which means two clinics running the same brand of tube can hand you preparations that differ several fold in platelet concentration and differ entirely in white cell content. A standardized protocol is just the written recipe that pins down every variable capable of changing what actually reaches your follicles.
A protocol counts as standardized only when both halves are fixed in writing, the preparation variables from draw volume through measured platelet concentration factor and the delivery variables from injection depth through session interval, which is why a clinic that can state its centrifugation settings and its concentration factor is running a protocol and one that can't is running an improvisation.
What specific preparation parameters must be fixed before a PRP protocol can be called standardized?
Six numbers carry most of the weight here, and a protocol that names all six is meaningfully standardized while one that names three isn't. Miss any of them and you've been handed a description of a procedure without a description of a dose.
- Draw Volume: Reported systems run from around ten millilitres of whole blood to well over a hundred.
- Spin Force and Time: Stated as relative centrifugal force rather than RPM, paired with duration and one spin or two.
- Retained Volume: Taking three millilitres off the plasma layer instead of six roughly doubles the concentration factor.
- Concentration Factor: Measured against your own pre spin count, with most protocols aiming for three to six times baseline.
- Anticoagulant: Usually acid citrate dextrose or sodium citrate, which preserve platelet membranes better than heparin based options.
- Activation and Standing Time: Whether calcium chloride or thrombin is added, and how long the product may wait before injection.
A preparation protocol qualifies as standardized only when it names draw volume, relative centrifugal force and spin time, retained plasma volume, a measured concentration factor of typically three to six times the patient's own baseline, the anticoagulant used, and the activation and maximum standing time.
Why does platelet yield vary so widely between clinics using similar equipment?
Most people assume the machine sets the yield. It doesn't. The single most sensitive step in the whole process is manual and unmeasured, a person deciding by eye where the plasma layer ends and drawing it off.
- The Pipette Draw: A millimetre too high leaves platelets behind; too deep drags in red cells.
- Spin Architecture: Single spin systems dilute across more plasma; double spin concentrates harder into less.
- Your Own Baseline: Healthy adult counts range roughly 150,000 to 400,000 per microlitre before anything spins.
- What Gets Quoted: A volume in millilitres isn't a dose; a device name isn't a concentration.
Published comparisons of commercial PRP systems have found final platelet concentrations differing by roughly an order of magnitude across devices, and studies holding the device constant while varying the operator still find clinics injecting products that differ by a factor of four or five.
Which classification systems exist for reporting PRP composition and what does each one capture?
Several competing schemes exist because the field kept discovering that the previous one left out something that mattered. You'll see their labels used loosely in marketing, but the value isn't the label. It's the discipline of having to fill in every field.
No regulator requires a PRP composition code and most journals only encourage one, so what matters clinically isn't which scheme a clinic picks but whether it can fill in every field of any of them, because filling them in means the product was measured rather than assumed.
Which injection variables belong in the protocol definition alongside preparation?
Preparation decides what's in the syringe. Injection decides whether any of it lands where your follicles actually live, and a needle placed subcutaneously just deposits growth factors in fat.
- Depth: Mid to deep dermis, roughly three to five millimetres in scalp skin.
- Needle and Grid: Fine gauge, commonly twenty seven to thirty, points spaced about a centimetre apart.
- Volume Per Point: Around a tenth of a millilitre each, so the total is distributed rather than pooled.
- Zone Mapping: The same crown, midscalp or hairline zones covered each session, recorded on a diagram.
An injection depth of roughly three to five millimetres into the mid to deep dermis, a grid spaced about one centimetre apart delivering around a tenth of a millilitre per point, and a written zone map belong in the protocol definition alongside every preparation parameter.
What treatment interval and session count does a defined protocol specify?
Timing isn't administrative detail here, it's dosing. A follicle you stimulate today won't produce a visibly thicker shaft for three to six months, so the schedule is built around the hair cycle rather than around your diary.
- Induction: At least three sessions spaced about a month apart, sustaining a signal rather than delivering isolated pulses.
- Assessment: Standardized photography at baseline and again around six months, since checking at eight weeks measures nothing useful.
- Maintenance: Repeat sessions at roughly three to six month intervals, because the androgen driven miniaturisation isn't cured.
- Stop Rule: No measurable change six months after a properly delivered course means revisiting the diagnosis or candidacy, not extending.
A defined protocol specifies an induction phase of at least three sessions about a month apart, assessment by standardized photography at around six months, and maintenance every three to six months, which makes the honest price the cost of induction plus years of maintenance rather than the per session figure.
What records should a clinic keep to show its protocol is reproducible?
Reproducibility is a paperwork discipline before it's a clinical one. Every operator dependent step in this procedure is a place where the written protocol and an undocumented habit quietly drift apart, and the records are the only thing that tells you which one you got.
- Session Record: Date, operator, draw volume, tube lot, spin settings, retained volume, zones, depth, interval.
- Protocol Document: A versioned written recipe with a revision date, updated whenever tubes or centrifuges change.
- Equipment Logs: Service and calibration records, which turn a written g force into a real one.
- Photography Standard: Fixed camera distance, lighting, head positioning and part lines, ideally a mounted rig.
A clinic can only show its protocol is reproducible if it keeps a per session record covering draw volume, centrifuge settings, retained volume, any measured platelet counts, zones treated, needle and depth and interval, backed by a version controlled protocol document, centrifuge calibration logs, and a fixed photography standard.
How do regulators treat the consistency of platelet rich plasma preparation?
Regulators mostly govern the equipment and the handling, not the recipe, and that gap explains a great deal about why protocols vary. Nothing in the sequence of drawing your blood, spinning it, and returning it the same day triggers biologic licensing. What carries a marketing authorization is the separation system, not the treatment.
No regulator anywhere currently requires a clinic to hit a defined platelet dose, and clearance of a separation device certifies neither a platelet concentration nor an injection schedule and in most cases doesn't name androgenetic alopecia at all, which makes scalp injection an off label use of the device and makes standardization something a clinic has to impose on itself.
What risks does a patient carry when a clinic works without a documented protocol?
The dominant risk here isn't injury, it's expensive nothing. Autologous PRP has a genuinely reassuring safety profile, and the common complaints are transient scalp pain, swelling, pinpoint bleeding, headache and temporary shedding. What an undocumented protocol reliably produces is an unanswerable question at the end of a course you've already paid for.
- No Diagnosable Failure: You can't separate underdosing from wrong depth from drifted intervals from non response.
- Dose Drift: Four sessions at four different effective doses isn't a course, and partial gains can't be repeated.
- Handling, Not Dose: Sterility during transfer, correct labelling, and respect for scalp vascular anatomy need documented procedure.
- No Transferable History: Change clinics and the next provider inherits nothing usable, so a partial result can't be reproduced.
Ask any clinic what centrifugation settings it uses, what platelet concentration factor it achieves relative to baseline and how that was measured, what injection depth and grid it works to, and whether it takes standardized before and after photographs, because vague reassurance or brand names offered in place of numbers means there is no protocol to hold anyone to.
How do leukocyte rich and leukocyte poor preparations differ when injected into the scalp?
This one turns on whether the neutrophils sitting in the buffy coat get collected on purpose or deliberately left behind. The case for bringing them along comes largely from tendon and antimicrobial work, where a more aggressive catabolic and immune response is part of the remodelling the tissue needs. Your scalp is a poor match for that reasoning.
| Criteria | Leukocyte Rich | Leukocyte Poor |
|---|---|---|
| Cell content | Concentrated neutrophils alongside platelets | Most white and red cells left behind |
| Cargo | Proteases, myeloperoxidase, inflammatory mediators | Growth factors with a lighter inflammatory load |
| Scalp rationale | Borrowed from tendon and antimicrobial use | Keeps neutrophil load low in delicate cycling tissue |
| Tolerability | More soreness and swelling reported, inconsistently | Generally easier across a multi session course |
Mechanism and tolerability lean leukocyte poor for the scalp while head to head outcome data in androgenetic alopecia remain inconclusive, so a protocol should state which type it produces rather than leaving it to be inferred, and a clinic is better served committing to one consistently than varying it patient by patient without a measured reason.
